Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001464583-26-000002

CHIEF ACCOUNTING OFFICER gave up 3,205 shares (to pay taxes)

  • CHIEF ACCOUNTING OFFICER acquired 372 shares (grant or award)
  • CHIEF ACCOUNTING OFFICER acquired 7,564 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R CHIEF ACCOUNTING OFFICER 2026-01-15 Grant or award +372 $24.16 $8,988 27,418 D: show line 1 in the form
Megna Michael R CHIEF ACCOUNTING OFFICER 2026-04-01 Option exercise +7,564 34,982 D: show line 2 in the form
Megna Michael R CHIEF ACCOUNTING OFFICER 2026-04-01 Shares withheld for taxes −3,205 $48.13 $154,257 31,777 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R CHIEF ACCOUNTING OFFICER 2026-04-01 Grant or award · Share Option +14,600 14,600 D: show line 4 in the form
Megna Michael R CHIEF ACCOUNTING OFFICER 2026-04-01 Grant or award · Restricted Share Unit +3,650 3,650 D: show line 5 in the form
Megna Michael R CHIEF ACCOUNTING OFFICER 2026-04-01 Grant or award · Performance Share Unit +7,300 7,300 D: show line 6 in the form
Megna Michael R CHIEF ACCOUNTING OFFICER 2026-04-01 Option exercise · Restricted Share Unit −2,558 2,557 D: show line 7 in the form
Megna Michael R CHIEF ACCOUNTING OFFICER 2026-04-01 Option exercise · Restricted Share Unit −2,362 4,725 D: show line 8 in the form
Megna Michael R CHIEF ACCOUNTING OFFICER 2026-04-01 Option exercise · Restricted Share Unit −2,644 7,931 D: show line 9 in the form
Loading xslF345X06/form4-04032026_080430.xml…